Rafferty Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600K | Sell |
|
|||||
|
2025
Q1 | $1.3M | Sell |
|
|||||
|
2024
Q4 | $2.28M | Buy |
|
|||||
|
2024
Q3 | $3.03M | Buy |
|
|||||
|
2024
Q2 | $2.29M | Sell |
|
|||||
|
2024
Q1 | $5.31M | Buy |
|
|||||
|
2023
Q4 | $3.28M | Sell |
|
|||||
|
2023
Q3 | $3.34M | Buy |
|
|||||
|
2023
Q2 | $4.55M | Buy |
|
|||||
|
2023
Q1 | $3.95M | Sell |
|
|||||
|
2022
Q4 | $2.99M | Buy |
|
|||||
|
2022
Q3 | $3.27M | Buy |
|
|||||
|
2022
Q2 | $1.98M | Sell |
|
|||||
|
2022
Q1 | $3.3M | Sell |
|
|||||
|
2021
Q4 | $4.88M | Buy |
|
|||||
|
2021
Q3 | $3.03M | Buy |
|
|||||
|
2021
Q2 | $2.68M | Sell |
|
|||||
|
2021
Q1 | $3.27M | Buy |
|
|||||
|
2020
Q4 | $405K | Sell |
|
|||||
|
2020
Q3 | $1.05M | Buy |
|
|||||
|
2020
Q2 | $601K | Buy |
|
|||||
|
2020
Q1 | $145K | Sell |
|
|||||
|
2019
Q4 | $2.33M | Sell |
|
|||||
|
2019
Q3 | $4.06M | Sell |
|
|||||
|
2019
Q2 | $4.69M | Buy |
|
|||||
|
2019
Q1 | $4.87M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $806K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $2.42M | Buy |
|